Trim 30-50% of position into breakdown; set stops at $180-182 (not $187); preserve capital with clear re-entry framework below $190

• $289 billion backlog is contracted revenue, not risk-free profit—fixed-price terms face inflation and tariff-driven cost overruns
• Beta of 0.29 measures market correlation, not interest rate sensitivity—rising discount rates compress present value of long-dated cash flows regardless of beta
• Polymarket pricing 96% probability of zero cuts in 2026 signals regime change, not tail risk
• Three percent drop on single Hormuz headline reveals fragility of geopolitically-derived multiple premium
• 11 consecutive RSI sessions below 35 marks persistent downtrend distribution, not oversold exhaustion—RSI can stay pinned below 30 for months in confirmed breakdowns
• Corrected PEG ratio is 1.6x, not 0.64x—still rich for an industrial at 24.3x forward P/E and 38% EPS growth under macro threat
• $9.88 billion in trailing free cash flow with zero buybacks signals informed insider caution, not capital discipline
• 30-50% trim proposal is prudent risk management after 49% rally from $151 to $225, not bearish positioning
• $187 stop is too tight given $4.18 ATR—proper stops require 1.5-2 ATR cushion, placing risk management at $180-182
• A 30 percent loss requires a 43 percent gain to recover—drawdown asymmetry demands capital preservation over return maximization

→ vs aggressive: Backlog conflates revenue with profit—fixed-price terms face inflation squeeze, GTF inspection costs, and tariff-driven cost overruns

→ vs aggressive: Beta argument is analytically wrong—low beta doesn't protect against rising rates; discount rate sensitivity crushes long-dated cash flows regardless of market correlation

→ vs aggressive: RSI oversold argument is dangerous—11 consecutive sessions below 35 signals persistent distribution, not exhaustion; buying oversold in confirmed breakdown with MACD accelerating negative is falling knife territory

→ vs aggressive: Forward P/E of 24.3x at 1.6x PEG (not 0.64x) is rich for an industrial with 38% EPS growth now under macro threat

→ vs aggressive: Zero buybacks is insider signaling, not balance sheet healing—management with unique visibility into order flow and program risk chooses not to buy at current prices

→ vs aggressive: $187 stop is far too tight at less than one ATR ($4.18) in confirmed volatility expansion—proper stops at $180-182 avoid noise shakeouts

→ vs aggressive: Framing cash as a sin ignores drawdown asymmetry—a 30% loss requires 43% recovery; first job of risk management is preventing catastrophic loss

→ vs neutral: Hold with bias to add below $190 is intellectually inconsistent—alternative to chasing is disciplined trimming, not passive holding

HOLD with 15-25% trim; re-entry at $195.80 close above 10 EMA with RSI above 40, MACD bullish cross, and higher low above $187 within 5-10 sessions

• Aggressive Analyst's beta argument is analytically wrong - beta measures equity market correlation, not interest rate or duration sensitivity
• Single-session 3% drop on Hormuz headline is empirical proof of geopolitical premium - cannot be dismissed as noise
• RSI reading of 27.82 with 11 sessions below 35 confirms orderly downtrend, not exhaustion - reading it as bullish is backwards
• Conservative Analyst overstates bear case on backlog - $289 billion backlog representing >100% of market cap provides unmatched multi-year revenue visibility in industrials
• Revenue grew 14.5% YoY, operating income grew 31%, FCF $9.88 billion trailing, deleveraged $8 billion in four quarters, dividend growing
• Management's zero buyback decision is legitimate capital allocation prioritizing debt reduction, not insider signal on valuation
• Conservative Analyst's 30-50% trim is too aggressive for a fundamentally healthy company near major technical support
• Recommended stop on remaining position at $181-$182 (1.5-2 ATR given ATR $4.18), not $187 or $185
• Four-factor re-entry framework is sound: close above 10 EMA at $195.80, RSI recovery above 40, MACD bullish cross, higher low above $187
• Balanced view preserves exposure to backlog conversion and operating leverage story while reducing risk in mixed technical/macro environment

→ vs aggressive: Beta argument is embarrassing - conflates market correlation with interest rate sensitivity; low-beta defensives got crushed in 2022 when the Fed hiked because long-duration cash flows were repriced lower

→ vs aggressive: $187 stop is bad risk management - barely one ATR below entry with acknowledged volatility expansion means the stop is designed to get hit by noise, not structural breaks

→ vs aggressive: Characterizing the 3% Hormuz drop as a gift is analytical malpractice - a single diplomatic headline causing that move proves meaningful geopolitical premium exists in the valuation

→ vs conservative: Backlog framing as 'just a revenue line' is reductive - $289 billion backlog representing >100% of market cap provides structural pricing power and capital allocation advantage

→ vs conservative: Bear case anchored too heavily on macro stress scenario that may not materialize as priced - Polymarket's 96% probability of zero cuts is a prediction market signal, not certainty

→ vs conservative: 30-50% trim treats a fundamentally healthy company as impaired - revenue +14.5% YoY, operating income +31%, FCF $9.88B, deleveraged $8B in four quarters is not a broken company